- Home
- EVF vs ANEB Comparison
EVF vs ANEB Comparison
Compare EVF & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- ANEB
- Stock Information
- Founded
- EVF 1998
- ANEB 2020
- Country
- EVF United States
- ANEB United States
- Employees
- EVF N/A
- ANEB N/A
- Industry
- EVF Investment Managers
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- EVF Finance
- ANEB Health Care
- Exchange
- EVF Nasdaq
- ANEB Nasdaq
- Market Cap
- EVF 101.0M
- ANEB 111.8M
- IPO Year
- EVF N/A
- ANEB 2021
- Fundamental
- Price
- EVF $5.42
- ANEB $2.38
- Analyst Decision
- EVF
- ANEB Buy
- Analyst Count
- EVF 0
- ANEB 2
- Target Price
- EVF N/A
- ANEB $8.00
- AVG Volume (30 Days)
- EVF 93.3K
- ANEB 24.8K
- Earning Date
- EVF 01-01-0001
- ANEB 11-14-2025
- Dividend Yield
- EVF 10.68%
- ANEB N/A
- EPS Growth
- EVF N/A
- ANEB N/A
- EPS
- EVF 0.94
- ANEB N/A
- Revenue
- EVF N/A
- ANEB N/A
- Revenue This Year
- EVF N/A
- ANEB N/A
- Revenue Next Year
- EVF N/A
- ANEB N/A
- P/E Ratio
- EVF $6.74
- ANEB N/A
- Revenue Growth
- EVF N/A
- ANEB N/A
- 52 Week Low
- EVF $5.20
- ANEB $0.80
- 52 Week High
- EVF $6.84
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- EVF 43.31
- ANEB 35.48
- Support Level
- EVF $5.38
- ANEB $2.33
- Resistance Level
- EVF $5.50
- ANEB $2.65
- Average True Range (ATR)
- EVF 0.04
- ANEB 0.08
- MACD
- EVF 0.00
- ANEB -0.04
- Stochastic Oscillator
- EVF 33.36
- ANEB 1.15
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.